Hemoglobin Testing Devices Market to USD 1.8 Billion by 2020

Hemoglobin Testing Devices Market to USD 1.8 Billion by 2020

According to a market research report Hemoglobin Testing Devices Market 2016-2020, published by iHealthcareAnalyst, Inc., the global hemoglobin testing devices market is estimated to reach USD 1.8 Billion in 2020, expanding at a CAGR of 8.4% from 2016 to 2020.

Visit the Hemoglobin Testing Devices Market 2016-2020 report at https://www.ihealthcareanalyst.com/report/hemoglobin-testing-devices-market/

Hemoglobin is a protein inside red blood cells that carries oxygen throughout the body. A hemoglobin test (Hb, Hgb) reveals the level of hemoglobin in a person’s blood, helping to diagnose and monitor anemia and polycythemia vera. A Hemoglobin A1c test is an important measure of how well a person with diabetes is controlling their blood glucose level.

The global hemoglobin testing devices market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).

The global hemoglobin testing devices market segmentation is based on technologies (boronate affinity chromatography, direct enzymatic assay, immunoassay, ion-exchange HPLC, micro-optical detection method, capillary electrophoresis) and end users (laboratory testing devices, point-of-care testing devices). The global hemoglobin testing devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global hemoglobin testing devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

  1. Technology
    • Boronate Affinity Chromatography
    • Direct Enzymatic Assay
    • Immunoassay
    • Ion-Exchange HPLC
    • Micro-Optical Detection Method, Capillary Electrophoresis, etc.
  1. End User
    • Laboratory Testing Devices
    • Point-of-Care (POC) Testing Devices
  1. Geography (Region, Country)
    • North America (U.S., Canada)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World
  1. Company Profiles
    • Abbott Laboratories
    • Alere, Inc.
    • ARKRAY, Inc.
    • Bio-Rad Laboratories, Inc.
    • Chek Diagnostics (Polymer Technology Systems, Inc.)
    • Danaher Corporation (Beckman Coulter)
    • EKF Diagnostics Holdings plc
    • Hoffmann-La Roche Ltd.
    • Menarini Group
    • Sebia
    • Siemens Healthcare
    • Tosoh Corporation
    • Trinity Biotech plc

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]
Website: https://www.ihealthcareanalyst.com


 

2017-09-19T20:19:27+00:00 Categories: Press Releases|